Pathophysiology of Pulmonary Fibrosis in the Context of COVID-19 and Implications for Treatment: A Narrative Review

Pulmonary fibrosis (PF) is a feared outcome of many pulmonary diseases which results in a reduction in lung compliance and capacity. The development of PF is relatively rare, but it can occur secondary to viral pneumonia, especially COVID-19 infection. While COVID-19 infection and its complications...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Son, Ksajikian, Andre, Overbey, Juliana, Li, Patrick, Li, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406710/
https://www.ncbi.nlm.nih.gov/pubmed/36010566
http://dx.doi.org/10.3390/cells11162489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406710/
https://www.ncbi.nlm.nih.gov/pubmed/36010566
http://dx.doi.org/10.3390/cells11162489

Ejemplares similares